HIGHLIGHTS
- who: Tiesheng Niu from the United States Kafkas University, Turkey have published the article: New R2-CHA2DS2-VASc score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention, in the Journal: (JOURNAL)
- what: The investigation demonstrated that R2 -CHA2 DS2 -VASc u2265 3 is the optimum cut-off value for predicting MACE with a sensitivity of 50% and a specificity of 91.1%. This study demonstrated that a variety of risk factors, including hypertension, hyperglycemia, renal dysfunction, and heart failure, may contribute to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.